Zepbound for Sleep Apnea: FDA Approves First Drug Treatment Option

Send us a message with this link, we would love to hear from you. Standard message rates may apply. (https://www.buzzsprout.com/twilio/tex...)


This week, we're discussing a significant development in the treatment of obstructive sleep apnea (OSA). The FDA has recently approved Zepbound, a medication used in combination with diet and exercise, as the first drug option for moderate to severe OSA in adults with obesity. We'll break down how Zepbound works by targeting hormones that reduce appetite, which leads to weight loss, and how this can improve OSA symptoms. We'll also explore the details of the clinical trials that led to this approval, including how they measured the medication's effectiveness and what potential side effects patients should be aware of.







Support the show (https://buymeacoffee.com/yourcheckup)


Production and Content: Edward Delesky, MD & Nicole Aruffo, RN
Artwork: Olivia Pawlowski